Back to Search
MARIA ARANGO, MD
MD
Family Medicine Physician
NPI: 1053313809Individual
Specialties, Licenses & Credentials
Research & Publications (20)
PF-00477736 mediates checkpoint kinase 1 signaling pathway and potentiates docetaxel-induced efficacy in xenografts.
PMID 19584159·Clin Cancer Res·2009
7-preclinical
Advancing bioluminescence imaging technology for the evaluation of anticancer agents in the MDA-MB-435-HAL-Luc mammary fat pad and subrenal capsule tumor models.
PMID 19118051·Clin Cancer Res·2009
4-observational
Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients.
PMID 18270239·BMJ·2008
4-observational
Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1.
PMID 18723486·Mol Cancer Ther·2008
7-preclinical
Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study.
PMID 18285705·Cancer Biol Ther·2008
3-trial
Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy.
PMID 18413795·Mol Cancer Ther·2008
7-preclinical
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.
PMID 18089725·Mol Cancer Ther·2007
7-preclinical
An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.
PMID 17483355·Cancer Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 5407 S MCCOLL RD STE B
EDINBURG, TX 78539 - Phone
- (956) 587-0088
Quick Facts
- NPI
- 1053313809
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile